Previous Article | Next Article ![]()
Journal of Virology, October 2004, p. 11371-11378, Vol. 78, No. 20
0022-538X/04/$08.00+0 DOI: 10.1128/JVI.78.20.11371-11378.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Liang Tang,2 John E. Johnson,2 and L. Andrew Ball1*
Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama,1 Department of Molecular Biology, The Scripps Research Institute, La Jolla, California2
Received 11 February 2004/ Accepted 18 June 2004
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
The structure and assembly of viruses from the Alphanodavirus genus of the Nodaviridae family have been studied extensively (reviewed in references 10 and 25). Nodaviruses are positive-sense RNA viruses that have 30-nm nonenveloped particles with T=3 icosahedral symmetry. Each particle is assembled from 180 copies of a capsid protein precursor (alpha), which is autocatalytically cleaved following assembly into the two mature capsid proteins beta and gamma (7). A copy of each of the two genome segments, RNA1 (3 kb) and RNA2 (1.3 kb), are coencapsidated in each virus particle (16, 21). Authentic nodavirus particles do not encapsidate nonviral RNAs or the subgenomic RNA3 (0.4 kb), which is synthesized during replication, indicating that there is specific selectivity for genomic RNA during particle assembly. Early data suggested that a stem-loop in RNA2 was the signal for encapsidation into the particles of the nodavirus Flock House virus (FHV) (31). However, expression of the capsid protein of FHV from RNA2 in the absence of RNA1 results in the assembly of virus-like particles (VLPs) that are morphologically indistinguishable from wild-type (wt) FHV particles (24); these particles encapsidate only 19% of the wt levels of RNA2, the rest of the RNA being heterologous in origin (15). In addition, replicating FHV RNAs are encapsidated more specifically than nonreplicating RNAs, and it has been suggested that this may be related to temporal regulation of capsid protein synthesis, RNA conformation, or factors related to the local environment within the cell (15). These data indicate that selective coencapsidation of nodavirus RNAs is a complex process.
Structural studies of two alphanodaviruses, FHV and black beetle virus, indicated that the genomic RNA forms an integral part of the capsid structure (5, 29), with a 10-nt duplex of RNA visible in the crystal structures forming part of a molecular switch that produces flat contacts between the asymmetric protein units along each twofold axis. The 3-Å crystal structure of wt PaV particles shared many features with earlier structures of nodavirus particles (27). In addition, 35% of the genomic RNA (a total of 1,500 nt) was visible and was shown to interact extensively with the N-terminal region of the 60 subunits of the capsid protein that surrounded the 12 fivefold symmetry axes. The RNA duplexes at the twofold axis of PaV particles were 24 nt long with an additional unpaired nucleotide at each end of the duplex, and together they formed a dodecahedral cage. Electron cryomicroscopy (cryoEM) and image reconstruction also clearly showed the dodecahedral RNA cage (27). The RNA duplex fitted well with a model based on A-form double-stranded RNA (dsRNA). However, the genome of PaV consists of two single-stranded segments, a 3,011-nt RNA1 that encodes the replicase and a 1,311-nt RNA2 that encodes the capsid proteins (13, 14, 30), and the primary sequence of the genome is incompatible with the degree of Watson-Crick base pairing implied by the observed dsRNA. Therefore, it seemed likely that interaction(s) with the capsid proteins was involved in the formation of the RNA structure.
To investigate the sequence-specific contribution of the genomic RNA to its three-dimensional arrangement in particles, we analyzed PaV VLPs that had a wt protein content but encapsidated predominantly nonviral RNAs. To minimize the amount of viral sequences present in our system we expressed only the 401-amino-acid capsid protein open reading frame (ORF) (without the RNA2 5' and 3' untranslated regions) from a recombinant baculovirus. We purified VLPs and determined that they encapsidated total amounts of RNA similar to those of wt PaV particles, but only about 6% of this RNA was derived from viral sequences. Image reconstruction from cryoEM showed that the degree of icosahedral order imposed on the encapsidated heterologous RNA was similar to that of viral genomic RNA in wt virus particles at comparable resolution.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Baculovirus construction and growth. To produce VLPs the PaV capsid protein was expressed by using the Bac-to-Bac expression system (Invitrogen). To generate the recombinant baculovirus bCAP, the PaV capsid protein ORF was amplified by PCR with Pfu-turbo (Stratagene) from the plasmid PaV2(0,0) (14) using two oligonucleotides. The first (5' AAACTGCAGTTACATGTACATTCCTGTTAGTTGATG 3') annealed to nucleotides 1202 to 1228 of RNA2 (underlined), which encode the C terminus of the capsid protein and the stop codon next to a PstI site. The second oligonucleotide (5' GAATTCAGCAAGATGGTATCAAGAACTAAGAATCG 3') included an EcoRI site followed by the nucleotides AGC and annealed to the nucleotides complementary to nucleotides 20 to 45 of RNA2 (underlined), which encode the start codon and the N terminus of the capsid protein. The EcoRI/PstI-digested PCR-amplified fragment was ligated into pFASTBAC-DUAL so that the capsid ORF was under the control of the polyhedrin promoter with the sequence context surrounding the translation initiation codon identical to the efficiently translated GP64 (3). The sequence of PaV capsid ORF was verified to be identical to that of wt PaV (14).
Following transposition of the expression cassette into the bacmid carried by E. coli DH10Bac (Invitrogen), bacmid DNA was prepared and an 80% confluent monolayer of Se-1 cells was transfected with bacmid DNA, using Cellfectin (Invitrogen). After 5 h of incubation at 28°C the transfection mix was removed and replaced by ExCell-401 containing serum. Three days posttransfection the baculovirus containing cell supernatant was recovered and clarified by low-speed centrifugation. The resulting recombinant baculovirus bCAP was passaged once in Se-1 cells and was titrated by plaque assay on Se-1 cells.
Purification of VLPs. Se-1 cells were seeded in 75-cm2 flasks and, upon reaching 80% confluency (approximately 3 x 107 cells/flask), were infected with bCAP at a multiplicity of infection of 20 PFU/cell. Following 4 days of incubation at 28°C, cells were lysed by addition of NP-40 to a final concentration of 0.5%. After 30 min at room temperature the cell lysates were frozen and thawed, clarified by centrifugation at 9,000 x g for 15 min, and treated with RNase A (10 ng/ml) for 2 h at room temperature. VLPs were then pelleted through a 30% sucrose cushion and purified on sucrose gradients as previously described (12). The yield of purified VLPs was about 200 µg per flask. Proteins were analyzed by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and on Western blots as previously described (11).
Preparation of radiolabeled PaV and VLPs. To radiolabel PaV, confluent BSR-T7/5 cells in 35-mm-diameter dishes were transfected with 50 ng of PaV virion RNA as previously described (11). After 3 days of incubation at 28°C the medium was replaced with medium containing 10 µg of actinomycin-D/ml for 20 min. The products of RNA replication were then metabolically labeled by incorporation of [3H]uridine (20 µCi/ml) for 5 h in medium containing 10 µg of actinomycin-D/ml. After a 24-h chase in complete medium, the cells were lysed by addition of NP-40 and were stored at 20°C.
To radiolabel VLPs, Se-1 cells were infected with bCAP and 3 days later the cell medium was removed and the products of protein synthesis were labeled by incorporation of [35S]Met-Cys (5 µCi/ml) for 6 h at 28°C in Sf900II medium lacking Met and Cys. After an 18-h chase by addition of complete ExCell-401 medium the cells were lysed by addition of NP-40 and stored at 20°C.
Cell lysates containing labeled PaV and VLPs were treated with RNase A, pelleted through 30% sucrose cushions, resuspended in 50 mM sodium phosphate buffer (pH 7.2), and stored at 20°C.
Analysis of labeled particles on gradients. 35S-labeled VLPs and 3H-labeled PaV were cosedimented on sucrose gradients as described previously (12) and were cobanded on CsCl gradients following the method described by Scotti (26). Briefly, radiolabeled particles were fixed in 3.7% formaldehyde at 4°C overnight, and then 200 µl of particles in 50 mM sodium phosphate buffer (pH 7.2) was mixed with 5.9 ml of 27% (wt/wt) CsCl in 50 mM sodium phosphate buffer (pH 7.2), layered on 5.9 ml of 42% (wt/wt) CsCl in 50 mM sodium phosphate buffer (pH 7.2), and centrifuged at 130,000 x g for 24 h at 20°C.
Following centrifugation, gradients were harvested on a piston gradient fractionator (Biocomp). The top 8 mm of the gradient was removed, and then 30 fractions each of 2 mm (about 280 µl) were collected with an air rinse for 2 s between each fraction. Aliquots of 100 µl from each fraction were diluted with 300 µl of water, mixed with 3.5 ml of Budget-solve scintillation cocktail (RPI), and counted by double-label liquid scintillation spectrometry in two windows: 5 to 200 for 3H and 240 to 655 for 35S.
RNA extraction and analysis. RNA was extracted using an RNAgents kit (Promega), and samples were resolved on denaturing 1% agarose-formaldehyde gels and visualized by staining with Sybr Gold nucleic acid gel stain (Molecular Probes). For Northern blot analysis RNAs were transferred to Nytran nylon membranes and were hybridized with 32P-labeled RNA probes using conditions described previously (23). Probes designed to hybridize to PaV genomic RNA were generated by in vitro transcription using a MAXIscript kit (Ambion) with SP6 polymerase from PCR templates that included the SP6 promoter adjacent to RNA1 (nt 2598 to 3011) or RNA2 (nt 908 to 1311) sequences. The RNA2 probe included 47 nt of heterologous sequence at the 3' end. Hybridized membranes were exposed to a phosphor screen and were visualized by a digital radioactivity imaging system (Molecular Dynamics Storm).
RNase protection assay. RNase protection assays were performed using the RPA III system (Ambion) following the manufacturer's instructions. Briefly, 32P-labeled probes were made for RNA2 as described above and were gel purified on 5% acrylamide-urea gels. Encapsidated RNAs were extracted from VLPs and PaV particles, and the concentration of RNA samples was calculated from absorbance at an optical density of 260 nm (OD260). The RNAs were diluted and the RNA concentration was confirmed by triplicate measurements of the absorbance at OD260 prior to hybridization of the RNA with a molar excess of probe overnight at 42°C. The samples were digested with RNase A/T1 (1/150 dilution of supplied enzyme mix) for 30 min at 37°C. Following precipitation, the protected probe was resolved by electrophoresis on denaturing acrylamide gels. Fixed and dried gels were exposed to a phosphor screen, and the protected RNA products were quantitated using ImageQuant software (Amersham Biosciences Products).
cryoEM and image reconstruction.
The VLPs were freeze-hydrated on holey electron microscopy grids and were examined by cryoEM as described previously (27). Briefly, a 5-µl droplet of VLP sample was applied onto a previously glow-discharged copper grid coated with a holey carbon film. After removal of the excess solution by blotting, the grid was plunged into ethane slush and transferred into liquid nitrogen. The grid was inserted into a Phillips CM120 electron microscope that used a Gatan 626 cryostage. Focal pairs of electron micrographs were recorded under the low-dose condition at a magnification of 45,000x. Electron micrographs were digitized with a Zeiss scanner. The original step size for scanning was 7 µm, and the images were averaged to yield a pixel size of 4.67 Å. A total of 3,346 particles were boxed from the closer-to-focus micrographs with the program EMAN (19) and were used in image reconstruction with the program SPIDER (6). As the particles were oriented preferentially with the icosahedral threefold axes perpendicular to the grids (Fig. 1A), we tilted the grids by 20° to compensate for the uneven angular distribution. Among the particles used in reconstruction, 2,052 were tilted images. The contrast transfer function was not corrected, as the positions of the first zero of the contrast transfer functions computed from both tilted and nontilted particles were beyond the resolution of the reconstruction. The resolution was 15.4 Å as estimated with the Fourier shell correlation method using a criterion of 0.5. To facilitate comparison with the cryoEM structure of wt PaV (27), the 15.4-Å VLP structure was computationally filtered to yield a 22-Å-resolution structure. The images shown in Fig. 5A to C were contoured at 1
above background. The difference maps shown in panels D, E, and F were contoured at 1.7, 1.0, and 0.8
above background, respectively.
|
|
| RESULTS |
|---|
|
|
|---|
Physical properties of VLPs. To compare their physical properties, wt virions and VLPs were differentially radiolabeled and analyzed by sedimentation on sucrose velocity gradients and by buoyant density on isopycnic CsCl gradients. VLPs were labeled by incorporation of [35S]Met-Cys into their proteins, whereas wt PaV particles were labeled by incorporation of [3H]uridine into their RNA. Samples of semipurified wt PaV and VLPs were mixed and cosedimented through a 15 to 45% sucrose velocity gradient. Gradient fractions were assayed by double-label scintillation spectrometry. To minimize the 35S spillover into the 3H window, about 10-fold more 3H counts were loaded on each gradient. wt PaV particles sedimented as a single sharp peak near the middle of the gradient centered on fraction 15 (Fig. 2A). The major peak of VLPs was in a similar position but reproducibly sedimented one fraction slower than wt PaV. The major VLP peak was slightly broader than that of wt virions, raising the possibility that the VLPs were more heterogeneous in size and/or mass. VLP preparations also reproducibly contained a second very minor peak that sedimented about six fractions faster than the main peak (fraction 21). Western blot analysis on fractions from VLP gradients (data not shown) showed that the minor peak contained capsid proteins, and a similar minor protein peak was detected by Western blot of PaV gradient fractions (data not shown). The ratio of uncleaved to cleaved protein did not appear to vary across the fractions. We attribute the 35S near the top of the gradient to label not incorporated in VLPs.
|
RNA encapsidated in VLPs. To characterize the RNAs encapsidated by VLPs we extracted RNAs from sucrose gradient-purified unlabeled wt PaV and VLPs and examined them by electrophoresis on denaturing agarose gels alongside total cellular RNA from mock- or bCAP-infected Se-1 cells (Fig. 3A). The mock- and bCAP-infected cell samples appeared very similar (Fig. 3A, lanes 4 and 5), showing a major doublet of rRNA of about 2 kb with a background smear of RNAs ranging between about 0.1 to 5.0 kb. As expected, wt PaV (Fig. 3A, lane 2) contained two RNAs of about 3 and 1.3 kb that correspond to genomic RNA1 and -2. In contrast, the VLPs contained a smear of RNAs ranging in size from less than 0.2 kb to about 4 kb with no predominant species (Fig. 3A, lane 3).
|
Quantitation of PaV RNA encapsidated in VLPs. To measure the relative amount of RNA2-related sequences encapsidated in VLPs compared to that in wt PaV, RNAs extracted from the two types of particles were analyzed with a quantitative RNase protection assay. An RNA probe complementary to the 3' 322 nt of the capsid protein ORF was hybridized in excess with the extracted RNA, unprotected probe was digested with a mixture of RNases, the protected RNA fragments were resolved on acrylamide gels, and the products were visualized by phosphorimaging. In the absence of RNase the probe remained intact (Fig. 4A, lane 8), whereas in the absence of template and the presence of RNase the probe was degraded (Fig. 4A, lane 7). A dilution series of PaV virion RNA (20 ng in lane 1, 30 ng in lane 2, 40 ng in lane 3, and 50 ng in lane 4) provided a standard curve for comparison of duplicate 100-ng samples of VLP RNA (lanes 5 and 6). For each sample a single major protected fragment was evident that was slightly smaller than the full-length probe due to removal of the unprotected noncomplementary 47 nt of the probe. An example of quantitation of the protected RNA in the wt PaV RNA samples (Fig. 4A, lanes 1 to 4) is graphed as a standard curve in Fig. 4B. The standard curve was repeated for each independent repetition of the experiment. Data pooled from several experiments (including two pools of RNA extracted independently from particles) showed that VLPs contained 22% (±1.4%) of the RNA2 content of wt PaV particles. Therefore, a maximum of one in four VLPs contained PaV-derived RNA.
|
Structure of RNA in VLPs. To examine the three-dimensional arrangement of the RNA in the VLPs, sucrose gradient-purified particles were analyzed by image reconstruction from cryoEM. Three-dimensional reconstruction of the VLPs was computed, and the resolution was estimated to be 15.4 Å (Fig. 5C). The surface view of these particles resembled the 23-Å cryoEM reconstruction of wt PaV virions (27), with the major features, such as the protrusions at the quasi-threefold axis, being easily discernible in both reconstructions. The higher resolution VLP image showed greater surface detail than the PaV reconstruction (Fig. 5A), and the differences may be a consequence of the different sizes of the data sets and the resolution of the reconstruction. The VLP reconstruction was computationally filtered at 22-Å resolution (Fig. 5B), and the surface view more closely resembled that of the 23-Å PaV map (Fig. 5A). For example, the surface pits on the twofold axis in the 15.4-Å VLP structure were almost invisible at 22-Å resolution.
Because the structure of wt PaV was determined by X-ray crystallography at 3-Å resolution (27), the electron density attributable to the capsid proteins could be subtracted from the PaV reconstruction to reveal the icosahedrally ordered components of the encapsidated RNA. When this approach was applied to authentic PaV, the results showed an internal dodecahedral cage that fitted well with the atomic model of the duplex RNA underlying the icosahedral twofold axes derived from the crystal structure (27). Using a similar approach, the arrangement of the mostly heterologous RNAs encapsidated by the VLPs was examined by using the wt capsid protein density to calculate a difference map for the VLP reconstruction. The VLP difference map revealed a cage of density (Fig. 5E and F) that was similar in shape to the dodecahedral cage of RNA duplexes seen in authentic virions (Fig. 5D). As noted for the surface views, the internal VLP image was more refined than that of wt PaV, but we attribute this to the difference in resolution as before. The ratio of average RNA to average protein density was computed by masking the RNA and protein regions of the VLP and wt PaV reconstructions (data not shown). These calculations suggested that the relative RNA:protein density ratio was equal or greater for the VLP reconstruction compared to that of the wt PaV reconstruction.
The evident removal of the capsid in the difference map is indicative of the high quality of the VLP reconstruction. At the higher resolution of the VLP difference image, the helical conformation of the RNA duplexes was more clearly visible. Superimposition of the 15.4-Å resolution VLP difference map with the RNA model from the PaV crystal structure (27) showed that the helical structure of the RNA seen in VLPs is consistent with the structure of RNA seen in wt PaV particles (Fig. 6). From these results, we conclude that a portion of the RNA encapsidated in VLPs formed a dodecahedral cage composed of duplexes situated under the twofold axes, and this cage was equivalent at this resolution to that seen in authentic PaV virions.
|
| DISCUSSION |
|---|
|
|
|---|
In this study we examined the specific contribution of the genomic RNA to formation of the icosahedrally ordered RNA conformation. To this end, VLPs were assembled from PaV capsid proteins expressed from a recombinant baculovirus. The PaV RNA sequence in the system was limited to the minimum required for capsid protein expression, i.e., the capsid protein ORF. The RNA-to-protein ratio of VLPs was compared to that of wt PaV virions using two independent approaches. The comparative buoyant density and RNA:protein ratios calculated from OD260 and OD280 indicated that the VLPs had a slightly lower ratio of RNA to protein than wt PaV virions. Because both types of particles were assembled from wt capsid proteins, we interpreted this to indicate that there was slightly less RNA encapsidated in VLPs than PaV virions. However, because neither of these methods directly measures the amount of RNA encapsidated, we concluded that the VLPs contain amounts of RNA similar to that of wt PaV. Quantitation of the encapsidated RNAs showed that the VLPs encapsidated only about 6% of the wt amount of PaV-specific RNAs. Thus, if VLPs and wt PaV virions contained similar total amounts of RNA, then only about 6% of the encapsidated RNA was PaV specific, the remaining RNA being of either cellular or baculovirus origin.
The three-dimensional arrangement of the VLP-encapsidated RNA was examined by cryoEM image reconstruction. To more clearly visualize the RNA, a difference map was produced by subtracting the icosahedrally ordered protein components seen by X-ray crystallography of native PaV particles (27). Implicit in this approach was the assumption that the structure of the capsid proteins in VLPs was indistinguishable from that in native particles. This assumption seemed reasonable, given that the vector-expressed protein was wt in sequence and the VLP protein profile was very similar to that of wt PaV (Fig. 1A). Strikingly, the difference map showed a dodecahedral cage of helical RNA density similar to that seen in wt PaV and was shown to fit well with the X-ray crystallographic model of A-form duplex RNA (Fig. 6). The level of RNA density in the VLP images was at least as great as that in wt virions. Because 35% of the encapsidated RNA was visible in wt virions and only about 6% of the RNA encapsidated in the VLPs was RNA2-related, we conclude that the observed three-dimensional arrangement reflects that of the predominant encapsidated RNA, which was heterologous in origin. These observations indicate that non-PaV RNA encapsidated in VLPs adopted a similar three-dimensional structure to that formed by the genomic RNAs in wt PaV particles.
There are several ways that RNA could contribute to its three-dimensional conformation in virions through either RNA-RNA or RNA-protein interactions. Both the generic ribose phosphate backbone and sequence-specific bases can be involved in these interactions. The data presented here imply that generic RNA interactions suffice to stabilize the dodecahedral cage of RNA duplexes within particles of PaV. Evidently the inner surface of the PaV capsid can confer the dodecahedral arrangement of duplex segments on RNA of generic sequence, presumably by relying primarily on interactions that involve the RNA backbone. Because the X-ray structure of PaV represents an averaging of all 30 RNA duplexes, it does not resolve individual specific bases and we therefore cannot rule out the possibility that the ordered RNA has a conserved sequence motif. However, it seems most likely that the dodecahedral cage is formed with little or no contribution from nucleotide sequence-specific interactions. Other structural elements that are not icosahedrally ordered and therefore not seen in this type of analysis may play important roles in particle assembly and stability.
The PaV RNA visualized by X-ray crystallography conforms to the geometry of A-form dsRNA (27). However, the nucleotide sequences of PaV RNA1 and -2 preclude the possibility of perfect Watson-Crick base pairing for more than a small fraction of the observed duplex (14). For example, the longest perfect inverted repeat anywhere in the PaV genome contains only 14 consecutive nucleotides. This strongly suggests that the RNA duplexes are stabilized less by Watson-Crick base pairing than by other interactions that are largely independent of the nucleotide sequence, such as base stacking and interactions between the ribose phosphate backbone and the capsid proteins. The formation of a similar helical structure from heterologous RNA in the PaV VLPs analyzed here supports this interpretation.
For the related nodavirus FHV, a shorter 10-nt duplex RNA was visualized in the X-ray crystal structure (5) and by cryoEM image reconstruction (4). The capsid protein sequences of FHV and PaV share only 41% identical amino acids (14). Before the present study, it was not clear whether the greater icosahedral order of the RNA in PaV capsids was determined by the capsid protein, programmed by the genomic RNA, or due to a combination of these factors. The clearly visible ordered RNA in PaV VLPs indicates that the direct contribution of the genomic sequence to the icosahedral RNA structure is minimal and suggests that the capsid protein is the main determinant in forming the 24-nt RNA duplexes. It appears that the capsid protein can organize the three-dimensional structure of heterologous RNAs with few, if any, nucleotide sequence constraints. This conclusion is consistent with the finding that synthetic FHV VLPs which were examined by X-ray scattering at low resolution (28) appeared to have RNA structure similar to that of wt FHV particles analyzed by cryoEM. Like the PaV VLPs, those from FHV contained predominantly heterologous RNAs (15, 24).
Although the icosahedral order of the RNA appears to be independent of the nucleotide sequence, the RNA encapsidated in nodavirus particles nevertheless plays an essential role in particle integrity. FHV VLPs that contained mainly nonviral RNA (15, 24) were more sensitive to protease digestion than wt particles, indicating that the authentic RNA plays a stabilizing role that is not fulfilled by heterologous RNAs (1). It is not yet known whether this difference is specifically related to the sequences, secondary structures, sizes, or other properties of the genomic RNAs.
During natural infection nodaviruses show high fidelity for specific encapsidation of their genomic RNAs. The determinants of specificity for PaV RNA encapsidation have not yet been investigated, and the experiments described here were not designed to address this question. Indeed, the RNA-protein interactions in fully assembled particles may not accurately reflect those responsible for RNA selection during the dynamic process of assembly. However, our results show that whatever the determinants of specificity are, PaV RNA itself is not necessary for formation of the structurally important RNA cage. Instead, it appears more likely that RNA duplex formation is a consequence of induced fit with the capsid proteins, whose juxtaposition creates specific binding sites for A-form duplex RNA. However, our results do not exclude the possibility that part of the selective mechanism for RNA encapsidation in PaV virions may be a requirement for the RNA to have the potential to form duplex elements and that not all RNAs have this potential. However, if such a requirement exists, it can evidently be satisfied by a wide variety of heterologous RNAs.
In conclusion, heterologous RNA encapsidated in PaV VLPs has icosahedrally ordered three-dimensional arrangement similar to that of genomic RNA encapsidated in wt virions. This demonstrates that factors other than the specific nucleotide sequence and other attributes of the genomic RNA are the main determinants of the formation of the structure. The significance of this RNA structure predicts that it may not be possible to form T=3 PaV capsids in the absence of the dodecahedral RNA cage. That is, mutations in the capsid protein that disrupt the formation of the RNA duplexes may also disrupt assembly so that particle formation is not achieved.
| ADDENDUM IN PROOF |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
This work was supported by grants to L.A.B. (NIH R01AI18270) and J.E.J. (NIH R01GM034220).
| FOOTNOTES |
|---|
Present address: School of Life Sciences, University of Queensland, St. Lucia 4072, Australia. ![]()
| REFERENCES |
|---|
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|